The Online Investor
Biotechnology M&A image Biotechnology M&A » By The Online Investor Staff, updated Tue., Apr. 20, 4:02 AM Recent mergers and acquisitions in the Biotechnology M&A category.

Slide #61. Techne Corporation Bionostics Holdings Limited

Acquirer: Techne Corporation (NASDAQ:TECH)
Acquiree: Bionostics Holdings Limited
Details: Techne Corporation (NASDAQ: TECH) (Techne) announced today that it has agreed to acquire 100% ownership of Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc. (Bionostics). Bionostics is a global leader in the development, manufacture and distribution of control solutions that verify the proper operation of in vitro diagnostic (IVD) devices primarily utilized in point of care blood glucose and blood gas testing. Biosnostics has strategic supply relationships with virtually all global IVD device Original Equipment Manufacturers (OEMs). The transaction is expected to close in the first quarter of fiscal 2014, subject to the satisfaction of customary closing conditions, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The acquisition is not subject to any financing contingencies.

Bio-Techne and its subsidiaries develop, manufacture and sell life science reagents, instruments and services for the research and clinical diagnostic markets.Co.'s segments include: Protein Sciences, which developes and manufactures purified proteins and reagent solutions, cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies; and Diagnostics and Genomics, which develops and manufactures diagnostic products, including Food and Drug Administration-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for Original Equipment Manufacturer.

TECH SEC Filing Email Alerts Service


Open the TECH Page at The Online Investor »

Company Name: 
Bio-Techne Corp
Stock buyback: 
TECH buyback
Website: 
www.bio-techne.com
Sector: 
Biotechnology
Number of ETFs Holding TECH: 
77
Total Market Value Held by ETFs: 
$2.66B
Total Market Capitalization: 
$16.11B
% of Market Cap. Held by ETFs: 
16.52%
 

Open the TECH Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (3.56 out of 4)
60th percentile
(ranked higher than approx. 60% of all stocks covered)

Analysts' Target Price:
TECH Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Biotechnology M&A - Slide 61 of 83 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.